| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |